T-cell lymphomas, a challenging disease: types, treatments, and future

Abstract

T-cell lymphomas are rare and aggressive malignancies associated with poor outcome, often because of the development of resistance in the lymphoma against chemotherapy as well as intolerance in patients to the established and toxic chemotherapy regimens. In this review article, we discuss the epidemiology, pathophysiology, current standard of care, and future treatments of common types of T-cell lymphomas, including adult T-cell leukemia/lymphoma, angioimmunoblastic T-cell lymphoma, anaplastic large-cell lymphoma, aggressive NK/T-cell lymphoma, and cutaneous T-cell lymphoma.

DOI: 10.1007/s10147-016-1045-2

4 Figures and Tables

Cite this paper

@article{Ma2016TcellLA, title={T-cell lymphomas, a challenging disease: types, treatments, and future}, author={Helen Ma and Maher Abdul-Hay}, journal={International Journal of Clinical Oncology}, year={2016}, volume={22}, pages={18-51} }